Skip to main content

US ClosedU.S. Closed

ALEC: Alector, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology.

52W Range

54thpctl

Volume

0.61×avg

Market Cap

259.80MUSD

P/E Ratio

-2.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Alector, Inc.

ALECNASDAQ Global Select·USD·Closed

Alector, Inc.

ALECNASDAQ·USD·Closed

$2.34

−2.09%

$2.34

−$0.05 (2.09%)

52W Range

54thpctl

Volume

0.61×avg

Mkt Cap

259.80MUSD

P/E

-2.1TTM

Div Yield

–ann